IMMUNOCORE

Immunocore is focused on the discovery and development of novel T cell receptor-based drugs to treat diseases with a high unmet need, including cancer and viral disease. The company’s expertise in engineering T Cell Receptors (TCRs) and linking them to an antibody fragment (scFv) known as anti-CD3, has led to its first product candidate, IMCgp100, entering clinical trials in patients with metastatic melanoma. The proprietary T Cell Receptor technology platform is well validated and can easily be manufactured for clinical and commercial supply in microbial systems. Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.

#SimilarOrganizations #People #Financial #Event #Website #More

IMMUNOCORE

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Health Care Medical Pharmaceutical

Founded:

2008-01-01

Address:

Abingdon, Oxfordshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.immunocore.com

Total Employee:

251+

Status:

Active

Contact:

+4401235438600

Email Addresses:

[email protected]

Total Funding:

808.83 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Font Awesome Apache Mobile Non Scaleable Content

Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

nmd-pharma-logo

NMD Pharma

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Current Advisors List

john-bell_image

John Bell Non-Executive Director @ Immunocore
Board_member

Current Employees Featured

bahija-jallal_image

Bahija Jallal
Bahija Jallal Chief Executive Officer @ Immunocore
Chief Executive Officer
2019-01-01

not_available_image

Brian Di Donato
Brian Di Donato Chief Financial Officer & Head of Strategy @ Immunocore
Chief Financial Officer & Head of Strategy
2020-05-01

ian-laing_image

Ian Laing
Ian Laing Non Executive Director @ Immunocore
Non Executive Director

david-berman_image

David Berman
David Berman Head of Research & Development @ Immunocore
Head of Research & Development
2018-01-01

Founder

bent-jakobsen_image

Bent Jakobsen

nick-cross_image

Nick Cross

Stock Details

Company's stock symbol is NASDAQ:IMCR

Investors List

general-atlantic_image

General Atlantic

General Atlantic investment in Post-IPO Equity - Immunocore

rtw-investments-llc_image

RTW Investments LLC

RTW Investments LLC investment in Post-IPO Equity - Immunocore

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Post-IPO Equity - Immunocore

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - Immunocore

blackrock_image

BlackRock

BlackRock investment in Series C - Immunocore

rtw-investments-llc_image

RTW Investments LLC

RTW Investments LLC investment in Series B - Immunocore

terra-magnum-capital-partners-tmcp_image

Terra Magnum Capital Partners (""""TMCP"""")""

Terra Magnum Capital Partners (""""TMCP"""")"" investment in Series B - Immunocore

general-atlantic_image

General Atlantic

General Atlantic investment in Series B - Immunocore

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series B - Immunocore

jdrf-t1d-fund_image

JDRF T1D Fund

JDRF T1D Fund investment in Series B - Immunocore

Key Employee Changes

Date	New article
2020-05-06	Immunocore appoints Brian Di Donato as Chief Financial Officer and Head of Strategy

Official Site Inspections

http://www.immunocore.com Semrush global rank: 1.62 M Semrush visits lastest month: 15.55 K

Host Informations
Whois Informations

Loading ...

More informations about "Immunocore" on Search Engine